Effect of Anemia in High-Risk Groups of Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 105, Issue 5, 2010, Pages 611-618

  Kurek, Tomasz ^a   Lenarczyk, Radosław ^a   Kowalczyk, Jacek ^a   Światkowski, Andrzej ^a   Kowalski, Oskar ^a   Stabryła Deska, Joanna ^a   Honisz, Grzegorz ^a   Lekston, Andrzej ^a   Kalarus, Zbigniew ^a   Kukulski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ACUTE HEART INFARCTION; ANEMIA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS;

AGE FACTORS; AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 76849084693     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.036     Document Type: Article

References (28)

1. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., and Ludbrook P. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge. Circulation 76 (1987) 142-154
2. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
3. Joosten E., Pelemans W., Hiele M., Noyen J., Verhaeghe R., and Boogaerts M.A. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology 38 (1992) 111-117
4. Smieja M.J., Cook D.J., Hunt D.L., Ali M.A., and Guyatt G.H. Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. Can Med Assoc J 155 (1996) 691-696
5. Jan K.M., and Chien S. Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. Am J Physiol 233 (1977) H106-H113
6. Brazier J., Cooper N., and Buckberg G. The adequacy of subendocardial oxygen delivery: the interaction of determinants of flow, arterial oxygen content and myocardial oxygen need. Circulation 49 (1974) 968-977
7. Weiskopf R.B., Viele M.K., Feiner J., Kelley S., Lieberman J., Noorani M., Leung J.M., Fisher D.M., Murray W.R., Toy P., and Moore M.A. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279 (1998) 217-221
8. Levy P.S., Kim S.J., Eckel P.K., Chavez R., Ismail E.F., Gould S.A., Ramez Salem M., and Crystal G.J. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol 265 (1993) H340-H349
9. Most A.S., Ruocco Jr. N.A., and Gewirtz H. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 74 (1986) 1085-1092
10. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 149 (2005) 391-401
11. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
12. O'Meara E., Clayton T., McEntegart M.B., McMurray J.J., Lang C.C., Roger S.D., Young J.B., Solomon S.D., Granger C.B., Ostergren J., Olofsson B., Michelson E.L., Pocock S., Yusuf S., Swedberg K., Pfeffer M.A., and CHARM Committees and Investigators. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 113 (2006) 986-994
13. Sabatine M.S., Morrow D.A., Giugliano R.P., Burton P.B., Murphy S.A., McCabe C.H., Gibson C.M., and Braunwald E. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
14. Nikolsky E., Aymong E.D., Halkin A., Grines C.L., Cox D.A., Garcia E., Mehran R., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Cohen D.A., Negoita M., Lansky A.J., and Stone G.W. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
15. Al Falluji N., Lawrence-Nelson J., Kostis J.B., Lacy C.R., Ranjan R., and Wilson A.C. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 144 (2002) 636-641
16. World Health Organization. Nutritional Anaemias: Report of a WHO Scientific Group (1968), World Heath Organization, Geneva, Switzerland
17. McCullough P.A., Adam A., Becker C.R., Davidson C., Lameire N., Stacul F., and Tumlin J CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 98 (2006) 5K-13K
18. Reinecke H., Trey T., Wellmann J., Heidrich J., Fobker M., Wichter T., Walter M., Breithardt G., and Schaefer R.M. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24 (2003) 2142-2150
19. Sarnak M.J., Tighiouart H., Manjunath G., MacLeod B., Griffith J., Salem D., and Levey A.S. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 40 (2002) 27-33
20. Gagnon D.R., Zhang T.J., Brand F.N., and Kannel W.B. Hematocrit and the risk of cardiovascular disease: the Framingham study: a 34-year follow-up. Am Heart J 127 (1994) 674-682
21. Archbold R.A., Balami D., Al-Hajiri A., Suliman A., Liew R., Cooper J., Ranjadayalan K., Knight C.J., Deaner A., and Timmis A.D. Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J 152 (2006) 1091-1095
22. Cavusoglu E., Chopra V., Gupta A., Clark L.T., Eng C., and Marmur J.D. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 98 (2006) 580-584
23. Kalarus Z., Lenarczyk R., Kowalczyk J., Kowalski O., Gasior M., Was T., Zebik T., Krupa H., Chodór P., Poloński L., and Zembala M. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am Heart J 153 (2007) 304-312
24. Yoshikawa H., Powell Jr. W.J., Bland J.H., and Lowenstein E. Effect of acute anemia on experimental myocardial ischemia. Am J Cardiol 32 (1973) 670-678
25. Silverberg D.S., Wexler D., Blum M., Keren G., Sheps D., Leibovitch E., Brosh D., Laniado S., Schwartz D., Yachnin T., Shapira I., Gavish D., Baruch R., Koifman B., Kaplan C., Steinbruch S., and Iaina A. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737-1744
26. Okonko D.O., Grzeslo A., Witkowski T., Mandal A.K., Slater R.M., Roughton M., Foldes G., Thum T., Majda J., Banasiak W., Missouris C.G., Poole-Wilson P.A., Anker S.D., and Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency ferric-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51 (2008) 103-112
27. Ponikowski P., Anker S.D., Szachniewicz J., Okonko D., Ledwidge M., Zymlinski R., Ryan E., Wasserman S.M., Baker N., Rosser D., Rosen S.D., Poole-Wilson P.A., Banasiak W., Coats A.J., and McDonald K. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 49 (2007) 753-762
28. Aronson D., Suleiman M., Agmon Y., Suleiman A., Blich M., Kapeliovich M., Beyar R., Markiewicz W., and Hammerman H. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 28 (2007) 1289-1296